nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.149	0.192	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.149	0.192	CbGbCtD
Lidocaine—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.112	0.144	CbGbCtD
Lidocaine—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.107	0.138	CbGbCtD
Lidocaine—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.075	0.0965	CbGbCtD
Lidocaine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0727	0.0936	CbGbCtD
Lidocaine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0685	0.0882	CbGbCtD
Lidocaine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0436	0.0561	CbGbCtD
Lidocaine—Obstruction—Cyclosporine—focal segmental glomerulosclerosis	0.027	0.218	CcSEcCtD
Lidocaine—Sensation of heat—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.133	CcSEcCtD
Lidocaine—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.0467	CcSEcCtD
Lidocaine—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.0296	CcSEcCtD
Lidocaine—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0262	CcSEcCtD
Lidocaine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0262	CcSEcCtD
Lidocaine—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.0262	CcSEcCtD
Lidocaine—SCN9A—nephron tubule—focal segmental glomerulosclerosis	0.00256	0.0997	CbGeAlD
Lidocaine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0198	CcSEcCtD
Lidocaine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00239	0.0193	CcSEcCtD
Lidocaine—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.0188	CcSEcCtD
Lidocaine—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00217	0.0846	CbGeAlD
Lidocaine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.0167	CcSEcCtD
Lidocaine—SCN4A—kidney—focal segmental glomerulosclerosis	0.00201	0.0782	CbGeAlD
Lidocaine—SCN10A—nephron tubule—focal segmental glomerulosclerosis	0.00195	0.0759	CbGeAlD
Lidocaine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.0157	CcSEcCtD
Lidocaine—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0156	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.0154	CcSEcCtD
Lidocaine—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00186	0.0724	CbGeAlD
Lidocaine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0149	CcSEcCtD
Lidocaine—SCN2A—cortex of kidney—focal segmental glomerulosclerosis	0.00173	0.0674	CbGeAlD
Lidocaine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0129	CcSEcCtD
Lidocaine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0127	CcSEcCtD
Lidocaine—SCN3A—kidney—focal segmental glomerulosclerosis	0.00156	0.0608	CbGeAlD
Lidocaine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0125	CcSEcCtD
Lidocaine—SCN3A—cortex of kidney—focal segmental glomerulosclerosis	0.00152	0.0592	CbGeAlD
Lidocaine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.0113	CcSEcCtD
Lidocaine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0112	CcSEcCtD
Lidocaine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0104	CcSEcCtD
Lidocaine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0103	CcSEcCtD
Lidocaine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.0103	CcSEcCtD
Lidocaine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0103	CcSEcCtD
Lidocaine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00994	CcSEcCtD
Lidocaine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00961	CcSEcCtD
Lidocaine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00957	CcSEcCtD
Lidocaine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00935	CcSEcCtD
Lidocaine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.00925	CcSEcCtD
Lidocaine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00881	CcSEcCtD
Lidocaine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00879	CcSEcCtD
Lidocaine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.00872	CcSEcCtD
Lidocaine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00846	CcSEcCtD
Lidocaine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00841	CcSEcCtD
Lidocaine—SLC22A5—nephron tubule—focal segmental glomerulosclerosis	0.00103	0.0401	CbGeAlD
Lidocaine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00825	CcSEcCtD
Lidocaine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0082	CcSEcCtD
Lidocaine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000964	0.00778	CcSEcCtD
Lidocaine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00096	0.00775	CcSEcCtD
Lidocaine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.00764	CcSEcCtD
Lidocaine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000944	0.00762	CcSEcCtD
Lidocaine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.00739	CcSEcCtD
Lidocaine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.00733	CcSEcCtD
Lidocaine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.00733	CcSEcCtD
Lidocaine—SLC22A5—kidney—focal segmental glomerulosclerosis	0.000905	0.0352	CbGeAlD
Lidocaine—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.0009	0.035	CbGeAlD
Lidocaine—CYP2B6—nephron tubule—focal segmental glomerulosclerosis	0.000894	0.0348	CbGeAlD
Lidocaine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00089	0.00718	CcSEcCtD
Lidocaine—SLC22A5—cortex of kidney—focal segmental glomerulosclerosis	0.000881	0.0343	CbGeAlD
Lidocaine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000878	0.00708	CcSEcCtD
Lidocaine—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000876	0.0341	CbGeAlD
Lidocaine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.00658	CcSEcCtD
Lidocaine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00653	CcSEcCtD
Lidocaine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000807	0.00651	CcSEcCtD
Lidocaine—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000791	0.0308	CbGeAlD
Lidocaine—CYP2B6—kidney—focal segmental glomerulosclerosis	0.000786	0.0306	CbGeAlD
Lidocaine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000784	0.00632	CcSEcCtD
Lidocaine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000776	0.00626	CcSEcCtD
Lidocaine—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.00077	0.03	CbGeAlD
Lidocaine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.00604	CcSEcCtD
Lidocaine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.00582	CcSEcCtD
Lidocaine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000669	0.0054	CcSEcCtD
Lidocaine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000651	0.00526	CcSEcCtD
Lidocaine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00484	CcSEcCtD
Lidocaine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000593	0.0231	CbGeAlD
Lidocaine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000584	0.0227	CbGeAlD
Lidocaine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00466	CcSEcCtD
Lidocaine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.00462	CcSEcCtD
Lidocaine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.00461	CcSEcCtD
Lidocaine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.00459	CcSEcCtD
Lidocaine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000539	0.00435	CcSEcCtD
Lidocaine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000478	0.0186	CbGeAlD
Lidocaine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00042	0.0164	CbGeAlD
Lidocaine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000409	0.0159	CbGeAlD
Lidocaine—SCN3A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000395	0.00539	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000384	0.00523	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000383	0.00522	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00038	0.00518	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.00038	0.00518	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000368	0.00503	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000368	0.00503	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000366	0.005	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000366	0.00499	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—COL4A3—focal segmental glomerulosclerosis	0.000364	0.00496	CbGpPWpGaD
Lidocaine—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000358	0.00489	CbGpPWpGaD
Lidocaine—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—focal segmental glomerulosclerosis	0.000357	0.00488	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000355	0.00485	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000352	0.0048	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000352	0.0048	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.00035	0.00478	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000339	0.00463	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000334	0.00456	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000322	0.00439	CbGpPWpGaD
Lidocaine—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000303	0.00414	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000297	0.00406	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—NOS2—focal segmental glomerulosclerosis	0.000296	0.00404	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—FN1—focal segmental glomerulosclerosis	0.000296	0.00404	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000296	0.00404	CbGpPWpGaD
Lidocaine—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—focal segmental glomerulosclerosis	0.000295	0.00403	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—COL4A4—focal segmental glomerulosclerosis	0.000295	0.00403	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000295	0.00402	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NOS2—focal segmental glomerulosclerosis	0.000292	0.00399	CbGpPWpGaD
Lidocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—focal segmental glomerulosclerosis	0.000286	0.00391	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000285	0.00389	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000282	0.00385	CbGpPWpGaD
Lidocaine—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—focal segmental glomerulosclerosis	0.000274	0.00374	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—COL4A1—focal segmental glomerulosclerosis	0.000271	0.0037	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000271	0.0037	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000271	0.0037	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000261	0.00357	CbGpPWpGaD
Lidocaine—EGFR—LPA receptor mediated events—MMP2—focal segmental glomerulosclerosis	0.00026	0.00355	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000257	0.00351	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—MMP2—focal segmental glomerulosclerosis	0.000254	0.00346	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.00025	0.00341	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000238	0.00325	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.000234	0.00319	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—COL4A3—focal segmental glomerulosclerosis	0.000229	0.00313	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000227	0.0031	CbGpPWpGaD
Lidocaine—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—focal segmental glomerulosclerosis	0.000226	0.00308	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MYH9—focal segmental glomerulosclerosis	0.000219	0.00298	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000211	0.00287	CbGpPWpGaD
Lidocaine—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	0.00021	0.00286	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000204	0.00278	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	0.000201	0.00275	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—CD79A—focal segmental glomerulosclerosis	0.000199	0.00271	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	0.000197	0.00269	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—SPP1—focal segmental glomerulosclerosis	0.000196	0.00268	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.000196	0.00267	CbGpPWpGaD
Lidocaine—EGFR—LPA receptor mediated events—MMP9—focal segmental glomerulosclerosis	0.000195	0.00267	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000194	0.00264	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—PCNA—focal segmental glomerulosclerosis	0.000193	0.00263	CbGpPWpGaD
Lidocaine—EGFR—AGE/RAGE pathway—MMP9—focal segmental glomerulosclerosis	0.000191	0.0026	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	0.000186	0.00254	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000185	0.00253	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.000184	0.00251	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.000179	0.00244	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000177	0.00242	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000174	0.00238	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—PCNA—focal segmental glomerulosclerosis	0.000172	0.00234	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00017	0.00233	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00017	0.00233	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	0.000169	0.0023	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—TRPC6—focal segmental glomerulosclerosis	0.000169	0.0023	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000167	0.00227	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000164	0.00224	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000164	0.00223	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00016	0.00218	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.00016	0.00218	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—SPP1—focal segmental glomerulosclerosis	0.000159	0.00217	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000156	0.00213	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.000156	0.00213	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000154	0.00211	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—SPP1—focal segmental glomerulosclerosis	0.000154	0.0021	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Telomerase—TGFB1—focal segmental glomerulosclerosis	0.000153	0.00209	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.000152	0.00207	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.00015	0.00205	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00015	0.00205	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.00015	0.00205	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	0.000149	0.00204	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—MMP2—focal segmental glomerulosclerosis	0.000139	0.0019	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MYH9—focal segmental glomerulosclerosis	0.000138	0.00188	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—SERPINE1—focal segmental glomerulosclerosis	0.000136	0.00186	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000131	0.00179	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—FN1—focal segmental glomerulosclerosis	0.000128	0.00175	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.000126	0.00172	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	0.000126	0.00172	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000125	0.00171	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000124	0.0017	CbGpPWpGaD
Lidocaine—SLC22A5—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	0.000122	0.00166	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00012	0.00164	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.00012	0.00164	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00012	0.00164	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	0.00012	0.00164	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000119	0.00162	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—MMP9—focal segmental glomerulosclerosis	0.000116	0.00158	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000116	0.00158	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000114	0.00156	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.000114	0.00156	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	0.00011	0.0015	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—MMP2—focal segmental glomerulosclerosis	0.000109	0.00148	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIAS1—focal segmental glomerulosclerosis	0.000108	0.00148	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—MMP9—focal segmental glomerulosclerosis	0.000104	0.00142	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	9.87e-05	0.00135	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	9.34e-05	0.00128	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	8.94e-05	0.00122	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	8.59e-05	0.00117	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	8.59e-05	0.00117	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	8.45e-05	0.00115	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	8.28e-05	0.00113	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—MMP9—focal segmental glomerulosclerosis	8.16e-05	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MYH9—focal segmental glomerulosclerosis	8.03e-05	0.0011	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	8.02e-05	0.00109	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP2—focal segmental glomerulosclerosis	7.74e-05	0.00106	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	7.7e-05	0.00105	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	7.59e-05	0.00104	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—LPL—focal segmental glomerulosclerosis	7.56e-05	0.00103	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	7.44e-05	0.00102	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	7.37e-05	0.00101	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP2—focal segmental glomerulosclerosis	7.11e-05	0.00097	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	7.08e-05	0.000966	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	7.08e-05	0.000966	CbGpPWpGaD
Lidocaine—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	7.06e-05	0.000964	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	7.01e-05	0.000956	CbGpPWpGaD
Lidocaine—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	6.87e-05	0.000938	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—LIPC—focal segmental glomerulosclerosis	6.86e-05	0.000937	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	6.82e-05	0.000931	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	6.77e-05	0.000924	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	6.73e-05	0.000919	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	6.72e-05	0.000917	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	6.54e-05	0.000892	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	6.44e-05	0.000879	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.41e-05	0.000875	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.19e-05	0.000845	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CTGF—focal segmental glomerulosclerosis	6.04e-05	0.000825	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MMP9—focal segmental glomerulosclerosis	5.82e-05	0.000794	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	5.66e-05	0.000773	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.65e-05	0.000771	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.57e-05	0.00076	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	5.44e-05	0.000742	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MMP9—focal segmental glomerulosclerosis	5.34e-05	0.000729	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.22e-05	0.000712	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	5.18e-05	0.000707	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.16e-05	0.000704	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP2—focal segmental glomerulosclerosis	5.07e-05	0.000692	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD79A—focal segmental glomerulosclerosis	4.86e-05	0.000664	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.8e-05	0.000655	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.6e-05	0.000627	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—LIPC—focal segmental glomerulosclerosis	4.56e-05	0.000623	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.46e-05	0.000609	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	4.39e-05	0.000599	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—LPL—focal segmental glomerulosclerosis	4.19e-05	0.000572	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	4.18e-05	0.000571	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	4.02e-05	0.000548	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4e-05	0.000546	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.98e-05	0.000543	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CD40LG—focal segmental glomerulosclerosis	3.96e-05	0.000541	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.93e-05	0.000536	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.91e-05	0.000534	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MMP9—focal segmental glomerulosclerosis	3.81e-05	0.00052	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.7e-05	0.000505	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	3.68e-05	0.000502	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.64e-05	0.000497	CbGpPWpGaD
Lidocaine—EGFR—Disease—LPL—focal segmental glomerulosclerosis	3.59e-05	0.00049	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AGT—focal segmental glomerulosclerosis	3.58e-05	0.000489	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.39e-05	0.000463	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.39e-05	0.000463	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—LIPC—focal segmental glomerulosclerosis	3.37e-05	0.00046	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.35e-05	0.000457	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.34e-05	0.000456	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.3e-05	0.00045	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.19e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	3.14e-05	0.000429	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.06e-05	0.000417	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.97e-05	0.000405	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.9e-05	0.000396	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	2.86e-05	0.00039	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOS2—focal segmental glomerulosclerosis	2.81e-05	0.000383	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.78e-05	0.00038	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ALB—focal segmental glomerulosclerosis	2.75e-05	0.000375	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.74e-05	0.000374	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.72e-05	0.000372	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.72e-05	0.000372	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.67e-05	0.000365	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.59e-05	0.000354	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.57e-05	0.000351	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-05	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.52e-05	0.000343	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	2.51e-05	0.000343	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.49e-05	0.00034	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.38e-05	0.000325	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.38e-05	0.000325	CbGpPWpGaD
Lidocaine—EGFR—Disease—SERPINE1—focal segmental glomerulosclerosis	2.36e-05	0.000322	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.34e-05	0.00032	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.33e-05	0.000318	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.32e-05	0.000317	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.32e-05	0.000316	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.19e-05	0.000299	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-05	0.000298	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.15e-05	0.000294	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.13e-05	0.00029	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.09e-05	0.000285	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.06e-05	0.000282	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—LPL—focal segmental glomerulosclerosis	2.06e-05	0.000281	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.05e-05	0.000279	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.02e-05	0.000275	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2.01e-05	0.000275	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.99e-05	0.000271	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.99e-05	0.000271	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.9e-05	0.00026	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.89e-05	0.000257	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.83e-05	0.000249	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.79e-05	0.000244	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AGT—focal segmental glomerulosclerosis	1.76e-05	0.00024	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.75e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	1.74e-05	0.000238	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.72e-05	0.000235	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	1.68e-05	0.000229	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.65e-05	0.000226	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.61e-05	0.00022	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.53e-05	0.000209	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.52e-05	0.000207	CbGpPWpGaD
Lidocaine—EGFR—Disease—TGFB1—focal segmental glomerulosclerosis	1.49e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	1.49e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.43e-05	0.000195	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.42e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ALB—focal segmental glomerulosclerosis	1.35e-05	0.000184	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.35e-05	0.000184	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.32e-05	0.00018	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.3e-05	0.000177	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.27e-05	0.000173	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.24e-05	0.00017	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.22e-05	0.000167	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.21e-05	0.000166	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.21e-05	0.000165	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	1.14e-05	0.000156	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.04e-05	0.000143	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	1.04e-05	0.000142	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	9.97e-06	0.000136	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	9.39e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.36e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	9.31e-06	0.000127	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	8e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	7.96e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.14e-06	8.38e-05	CbGpPWpGaD
